Search results
Actavis Generics [1] (formerly known as Watson Pharmaceuticals and Actavis plc, prior to the acquisition of Irish-based Allergan, Inc.) is a global pharmaceutical company focused on acquiring, developing, manufacturing and marketing branded pharmaceuticals, generic and over-the-counter medicines, and biologic products. Actavis has a commercial ...
Aug 2, 2016 · Teva’s acquisition of Actavis Generics improves international commercial opportunities and significantly enhances the global scale of its sales and R&D platforms.
All of our products undergo thorough safety monitoring and evaluation processes at every stage of a medicine's lifecycle. Learn more.
Sep 12, 2023 · Actavis, Inc. was involved in the development of a number of medications under its own brand as well as marketing many generic medications. The company was involved in several legal actions that claim it had engaged in unfair marketing practices and unethical price-fixing strategies.
- Editorial Staff, American Addiction Centers
Jul 27, 2016 · Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) (TASE:TEVA) and Allergan plc (NYSE:AGN) today announced that the U.S. Federal Trade Commission (FTC) has accepted the proposed consent order in connection with the pending acquisition of Allergan’s generics business (“Actavis Generics”) by Teva Pharmaceutical Industries Ltd.
Aug 3, 2016 · Teva Pharmaceutical Industries has completed its acquisition of Allergan’s Actavis Generics business for $40.5 billion.
People also ask
What does Actavis stand for?
What did Actavis do?
Is Actavis still a company?
What products does Actavis make?
With a portfolio of more than 1,800 molecules, Actavis produces a wide range of generic products in nearly every therapeutic area and format, from tablets and capsules to liquids, ointments and creams, to a broad range of effective dosage forms and complex delivery systems.
